Compare DYAI & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DYAI | ABLV |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2M | 32.9M |
| IPO Year | 2004 | N/A |
| Metric | DYAI | ABLV |
|---|---|---|
| Price | $0.95 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 529.9K | ★ 1.1M |
| Earning Date | 11-12-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $3,342,195.00 | ★ $114,319,869.00 |
| Revenue This Year | $12.52 | N/A |
| Revenue Next Year | $92.04 | N/A |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.71 | $0.55 |
| 52 Week High | $2.20 | $1.77 |
| Indicator | DYAI | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 56.93 |
| Support Level | $0.85 | $0.70 |
| Resistance Level | $1.03 | $1.30 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 48.28 | 42.08 |
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.